MIRM
Mirum Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$96.97
+11.42%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 44.24x
- P/S forward
- 8.15x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -116.83x
- Price / sales
- 13.05x
- Price / cash flow
- -23.34x
Enterprise value
- Enterprise value
- $6.7B
- EV / sales
- 13.81x
- EV / EBITDA
- -7.92x
- EV / EBIT
- -39.40x
- Market cap
- $6.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026